In this fascinating interview, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Michael Lanuti and thoracic surgeon and Leanne Ashrafian about Dr. Lanuti’s thoughts on the JCOG0802 trial and how he believes the wrong parameters were measured.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung cancer
January 13, 2026
This video depicts a minimally invasive sleeve resection of centrally located mucoepidermoid carcinoma in the right lower lobe, followed by complex airway reconstruction.
January 8, 2026
In this remarkable interview, CTSNet Editor-in-Chief Joel Dunning and CTSNet Senior Editor Leanne Ashrafian spoke with Dr. Gavin Wright about his thoughts on the JCOG0802 trial and why he prefers segmentectomy over lobectomy.
January 8, 2026
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Gavin Wright and CTSNet Senior Editor Leanne Ashrafian about Dr. Wright’s thoughts on the JCOG0802 trial and why he prefers segmentectomy over lobectomy.
December 23, 2025
In this study, the authors report the long-term outcomes of the randomized phase II NEOpredict-Lung trial, which evaluates short-course neoadjuvant nivolumab with or without the LAG-3 inhibitor relatlimab in resectable non-small cell lung cancer (NSCLC).
December 18, 2025
In this exceptional interview, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Nasser Altorki and CTSNet Senior Editor Leanne Ashrafian about the 10-year results from the JCOG0802 trial.
December 18, 2025
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Nasser Altorki and CTSNet Senior Editor Leanne Ashrafian about the 10-year results from the JCOG0802 trial.
October 23, 2025
The NeoCOAST-2 trial, published in Nature Medicine, evaluates the efficacy and safety of neoadjuvant durvalumab-based combination regimens for resectable stage IIA–IIIB non-small cell lung cancer (NSCLC).
October 21, 2025
This video demonstrates a robotic-assisted left upper lobe S1/2 bisegmentectomy for early-stage non-small cell lung cancer in a patient with a high body mass index and poor lung function.
October 16, 2025
This video demonstrates the removal of a failed Evolut transcatheter aortic valve replacement and its replacement with a 27 mm Mosaic biological aortic valve in a patient with advanced lung cancer.